BioSpace News Archive

MatriSys Bioscience, Inc., a leader in the field of microbiome-based therapeutics for the treatment of skin conditions, is pleased to announce the appointment of Dr. James Mackay to its Board of Directors.

Researchers from Moorfields Eye Hospital, Homerton NHS Trust, and University College London find EyeArt System to have 100% sensitivity in detecting vision-threatening retinopathy

MGB Biopharma, a biopharmaceutical company developing a novel class of anti-infectives, announces that its Phase II clinical study has met its endpoints of safety, efficacy, and dose selection.

Oxford Immunotec Global PLC, a global, high-growth diagnostics company, announces the release of the T-SPOT Discovery SARS-CoV-2 test kit.

IDEAYA Biosciences, Inc. announced that Yujiro S. Hata, Chief Executive Officer and President at IDEAYA Biosciences, is scheduled to participate in a fireside chat discussion hosted by Maury Raycroft, Ph.D., Equity Analyst, at the Jefferies Virtual Healthcare Conference on Tues, June 2, 2020 at 11:00 a.m. ET.

Invivoscribe to offer the LeukoStrat® CDx FLT3 Mutation Assay as an FDA approved kit with analysis software.

First published comparative data for key second-line (2L) advanced hepatocellular carcinoma (aHCC) treatments using a matching-adjusted indirect comparison (MAIC)

Axonics Modulation Technologies, Inc. announced the publication of the 1-year results from its ARTISAN-SNM study in the peer-reviewed journal Neurourology & Urodynamics https://doi.org/10.1002/nau.24376.

Samsung Biologics announced it has attained ISO22301 certification for additional business operations, demonstrating its unsurpassed commitment to ensuring client satisfaction and operational excellence through its world-class business continuity management system.

Multi-Target Collaboration Leverages Vividion’s Screening Platform to Discover and Develop Highly Selective Small Molecules for E3 Ligases and Select Oncology and Immunology Targets